KALA BIO, INC. Unbilled Receivables, Current
KALA BIO, INC. (KALA) had Unbilled Receivables, Current of $112.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:UnbilledReceivablesCurrent · last filed 2025-11-19
- 2025-06-30: Unbilled Receivables, Current $112.00K.
- 2025-03-31: Unbilled Receivables, Current $112.00K.
- 2024-12-31: Unbilled Receivables, Current $112.00K.
- 2024-06-30: Unbilled Receivables, Current $117.00K.
| Period end | Unbilled Receivables, Current |
|---|---|
| 2025-06-30 | $112.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $112.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $112.00K 10-Q · filed 2025-11-19 |
| 2024-06-30 | $117.00K 10-Q · filed 2024-08-06 |
| 2023-12-31 | $117.00K 10-Q · filed 2024-08-06 |
| 2023-09-30 | $117.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $117.00K 10-Q · filed 2023-08-04 |
| 2023-03-31 | $115.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $195.00K 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |